This paper comprehends systematic Quality by Design (QbD) based development of Normal-Phase High-Performance Thin-Layer Chromatography (NP-HPTLC) method for qualitative and quantitative estimation of anagliptin in bulk and in-house tablets. Chromatographic separation was executed out on aluminum backed Silica gel F254 plates using dichloromethane: methanol (9.2:0.8 v/v) as a mobile phase. Densitometry scanning was accomplished at 248 nm. Quality target method profile was defined and critical analytical attributes (CAAs) for the HPTLC method set aside. The mobile phase ratio and saturation time were determinate as critical method parameters (CMPs) and systematically optimized using Central composite design, evaluating for CAAs, namely retention factor (Rf), Peak-area and Peak-height. Statistical modelization was implemented followed by response surface analysis for comprehending plausible interaction(s) among CMPs. Search for optimum solution was conducted through numerical and graphical optimization for demarcating the design space. The described method was linear. The precision, ruggedness, and robustness values were also within the prescribed limit. The studies successfully demonstrate the utility of QbD approach for developing the highly sensitive HPTLC method with enhanced method performance.
Dipeptidyl peptidase-4 (DPP-4) inhibitors are promising new class of anti-diabetics. It increases level of incretin such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) which leads to increase glucose-dependent secretion of insulin and decreased blood glucose, haemoglobin A1C and glucagon levels [2] [3] [4] .
Quality by Design (QbD) concepts is well defined in ICH guidelines Q8 (R1): Pharmaceutical Development [5] , Q9: quality risk management [6] , and Q10: pharmaceutical quality system [7] .
The concept of QbD applied to analytical method development is known now as Analytical Quality by Design (AQbD) [8] . AQbD prevalence in development of a robust and cost effective analytical method which is applicable throughout the lifecycle of the product, to facilitate the regulatory flexibility in analytical method. It means the freedom to change method parameters within a method's design space, referred to as the method operable design region (MODR) [9, 10] .
The first step in this process is to define the Quality Target Method Profile (QTMP) or Analytical Target Profile (ATP). QTMP or ATP is a statement that defines the method's purpose which is used to drive method selection, design, and development activities. [11] After defining the QTMP, the next step is to ascertain the critical analytical attributes (CAAs) similar to Critical Analytical Attributes (CQA) in product development. According to ICH Q8 (R2) "A CQA is a physical, chemical, biological, or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality. Next to this is identification of critical method parameters (CMPs) using risk assessment and screening. In general, Ishikawa fishbone diagram can be used for risk identification and assessment. [12] Further, prioritization exercise is performed by employing initial risk assessment and QRM techniques for identifying the "high-flying few" input variables, termed as Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) from the "probable so many". This process is popularly termed as factor screening. Comparison matrix (CM), Risk Estimation Matrix (REM), Failure Mode Effect Analysis (FMEA) and Hazard Operability Analysis (HAZOP) are the examples of commonly employed risk assessment techniques. The low-resolution first-order experimental designs (e.g., fractional factorial, Plackett-Burman and Taguchi designs) are highly helpful for screening and factor influence studies. Once the potential and critical analytical method variables are defined with initial risk assessment, then DoE can be performed to confirm and refine critical method variables based on statistical significance. It can be determined per unit operation or combination of selected multiple method variables and their interactions and responses (critical method attributes). This approach provides an excellent opportunity to screen a number of conditions generated from a limited number of experiments. Then, data evaluations by using statistical tools are very important to identify critical method variables and the appropriate optimal ranges for method variables where a robust region for the critical method attributes could be obtained [13, 14] .
Literature survey revealed that UV-spectrophotometry method has been reported [15] .To our notice, so far no HPTLC method has been reported for the estimation of AGP in tablets. Attempts were, therefore, made to apply AQbD approach to develop simple, robust, sensitive, effective and economical NP-HPTLC method for estimation of AGP in bulk drug and tablets.
EXPERIMENTAL

Chemicals and Reagents
Pharmaceutical grade Anagliptin working standards were obtained as generous gifts from Glenmark Pharm., Nashik, India. Methanol (A.R. Grade) and aluminium backed TLC plates pre-coated with silica gel 60 F254 (0.2 mm thick) were purchased from E. Merck Ltd., Mumbai (India).
Instrumentation
The TLC plates were prewashed with methanol and activated at 110 o C for 5 min, prior to chromatography. The linear ascending development was carried out in 20 x 10 cm twin trough glass chamber (Camag, Muttenz, Switzerland) using dichloromethane: methanol (9.2: 0.8 v/v) as mobile phase, after saturation of the chamber with mobile phase vapour for 20 min. The development distance was 8 cm. After, chromatography plates were dried in a current of air with the help of air dryer. A Camag HPTLC system containing Camag Linomat 5 sample applicator, Hamilton syringe (100 µL), Camag TLC Scanner-3 with winCATS software version 1.3.0 and Camag twin-trough chamber (20 x 10 cm) were used for the present study. The source of radiation utilized was deuterium lamp emitting a continuous UV-spectrum between 200 to 400 nm.
Preparation of standard solution
Stock standard solution was prepared by dissolving 10 mg of AGP in 100 mL of methanol to get concentration of 0.1 mg/mL.
Selection of analytical wavelength
After chromatographic development bands were scanned over the range of 400 -200 nm and 248 nm was selected for estimation of drug.
Defining the ATP and CAAs
Analytical target profile is defined for HPTLC method for AGP and shown in Table 1 . In order to meet the desired ATP, various CAAs were identified, such as Peak-area, Peakheight and retention factor.
Risk assessment studies
Risk assessment studies were performed to identify the CMPs, which possess high risk based on their criticality and influence to affect the CAAs. Besides, risk assessment also furnishes expected interaction(s) among the CMPs and CPPs, estimating the chances of subsequent failure(s), if any. [12] The first step in the risk assessment was to systematically gather up all the possible factors that could influence method. These factors were organized hierarchically using an Ishikawa or "fishbone" diagram. Further, prioritization studies were carried out for selecting the CMPs/CPPs with high risk by FMEA risk assessment technique.
The outcome of an FMEA are risk priority numbers (RPN) for each combination of occurrence probability, failure mode severity, and possibility of detection, which can be used to rank the risk. FMEA defines the RPN as: where O is the occurrence probability or the likelihood of an event occurring; occurrence probability can be ranked as 5, likely to occur; 3, 50:50 chance of occurring; and 1, unlikely to occur. The next parameter S, the severity, which is a measure of how severe of an effect a given failure mode would cause; these can be ranked as 5, severe effect; 3, moderate effect; and 1, no effect. The final parameter D is the detectability or the ease that a failure mode can be detected, because the more detectible a failure mode is, the less risk it presents to product quality. For D, here rank 1 can be given to parameter which can be easily detectable, 3 as moderately detectable, and 5 as hard to detect. Using this procedure, we have calculated RPN for selecting CMPs.
Factor screening studies
Factor screening was done by using Taguchi design which is widely used screening design. For this seven factors were considered and eight plates were developed and scanned. Factor screening helps to identify CMPs which critically affecting CAAs (i.e., Retention factor, Peak-area and Peak-height). Table 2 shows the design matrix enlisting the studied factors and the decrypted translation of their respective low and high levels.
The design was analyzed for influence of studied factors on the CAAs. Model fitting was carried out for selecting linear polynomial model by obviating the interaction term(s). As screening is primarily based on the principle of factor sparsity, the Pareto charts were employed for quantitatively identifying the effect of each factor on the selected CAAs [16, 17] . 
Method development as per the experimental design and statistical analysis
Selection of CMPs actually affecting method performance based on preliminary risk assessment and factor screening pushed forward for further method optimization. Central composite design with α = 1 was used for optimization of selected CMPs, namely mobile phase ratio and saturation time studied at four levels, that is, low, intermediate, high, extremely high and extremely low. Table 3 summarizes a design matrix consisting of 13 experimental runs as per central composite design including a total of nine experimental runs together with five runs of center point (0, 0). A standard concentration of 300 ng per band was used for all the experimental runs, which were analyzed for CAAs, namely Rf, Peak-area, and Peak-height.
All the results were analyzed using statistical software Design Expert software version 9.0.6.2. (Stat-ease, Inc., Minneapolis, MN). The experimental data were validated by ANOVA combined with F-test. Only the coefficients, which were found to be significant (P˂ 0.05) as per ANOVA analyses, were considered in framing the polynomial equation. Other parameters like lack of fit, coefficient of correlation (r 2 ) and predicted error sum of squares (PRESS) were also evaluated to check the appropriate model fitting. Response surface analysis was carried out through estimated 2D-contour plots and 3D-response surface. As well as, the model diagnostic plots like normal plot of probability, run plot, residual plot and histogram plot were used to analyze the degree of fitness of the explored data. 
VALIDATION OF METHOD
The method was validated by establishing linearity, accuracy, inter-day and intra-day precision of measurement of sample application. The detection limit (DL) and quantification limit (QL) were also determined.
Linearity
Appropriate volumes in the range of 1 -6 mL were transferred from stock solution into series of 10 mL volumetric flaks and volumes were made up to mark with methanol. From each volumetric flask, 10 µL of solution was applied on HPTLC plate to get concentration in the range of 100 -600 ng per band. After evaporation of solvents at room temperature for 20 min, chromatography was performed as described above. Calibration curve was established by plotting Peak-area against drug quantity per band. Calibration equations were determined by use of linear regression analysis and correlation coefficients (r 2 ) were calculated. All measurements were repeated six times.
Repeatability and Intermediate Precision
The precision of the method was confirmed by repeatability and intermediate precision studies. Repeatability studies were executed by analysis of AGP (300 ng per band) six times on the same day. The intermediate precision of the method was checked by analysing three different concentrations 200 ng per band, 300 ng per band and 400 ng per band of AGP for three different days, over a period of week.
Recovery
The accuracy of the experiment was established by over spotting drug standard solution to the pre-analyzed sample solution. The recovery study was performed at three different levels i.e. 80, 100, and 120%. The experiment was repeated three times.
Robustness
For robustness study, the composition of the mobile phase was changed slightly and the effects on the results were examined. Dichloromethane: Methanol in different ratios (9.1:0.9; 9.2:.8; 9.3:0.7 v/v) were selected and chromatograms were run. The amount of mobile phase (10 ± 2 mL, i.e. 8, 10, or 12 mL), development distance (8 ± 0.5, i.e. 7.5, 8, 8.5) and duration of saturation (20 ± 5 min, i.e. 15, 20, or 25 min) were varied. Time from application of AGP to the plate to development of the plate and time from development of plate to scanning were also varied (10, 20, or 30 min).
The robustness and ruggedness of the method was assessed at concentration (300 ng per band) for six times.
Detection Limit (DL) and Quantification Limit (QL)
The DL and QL were calculated using the equations The DL was regarded as the amount for which the signal-to-noise ratio was 3:1 and QL as the amount for which the signal-to-noise ratio was 10:1. The DL and QL estimated at concentration range 100-200 ng per band.
Specificity
The specificity of the method was ascertained by analyzing standard AGP and AGP extracted from tablets. The band for AGP in sample was confirmed by comparing the Rf and spectra of the band with those obtained from standard. The peak purity of AGP was assessed by comparing spectra acquired at three different positions on the band, i.e. peak -start (S), peak-apex (M), and peak-end (E).
Analysis of Tablet formulation
Due to the unavailability of Anagliptin tablets in the local Indian market, In-house tablets were formulated via direct compression technique using commonly used excipients containing 100 mg of drug per tablet.
To determine the content of in-house prepared tablets of AGP, twenty tablets were weighed and powdered. An amount of powder equivalent of 10 mg of AGP was weighed accurately, transferred into 100 mL volumetric flask containing 50 mL of methanol, sonicated for 20 min, and solution was diluted up to 100 mL with same solvent. The resulting solution was filtered through Whatmann filter paper, extract (3 μL; 300 ng per band) was applied to a TLC plate followed by development and scanning as described above. The analysis was repeated for six times.
RESULTS
Preliminary optimization of mobile phase
The HPTLC procedure was optimized to develop assay method for determination of AGP in bulk and tablet formulation. The drug standard was applied on HPTLC plates and developed with different composition of mobile phases depending on polarity of drug. Mobile phase consisting of Dichloromethane and methanol showed symmetrical peak with low tailing.
Risk assessment studies
All the possible factors that could affect HPTLC method were systematically gathered and organised using Ishikawa or fishbone diagram as shown in Figure 2 .
Further prioritization studies were carried out by FMEA risk assessment technique and PRN were calculated for nine factors viz. Mobile phase ratio, mobile phase volume, development distance, relative humidity, duration of saturation, activation time of prewashed plates, time from spotting to chromatography, time from chromatography to scanning, and plate size.
In the present study, the greatest RPNs were used to identify the parameters which affect the method performance mostly and thus needed to be studied in more detail. Table 4 shows listing of the factors considered when doing the FMEA along with their RPN. From FMEA study, five factors identified such as mobile phase ratio, development distance, and relative humidity, duration of saturation and activation time of prewashed plates which were associated with high risk. 
Factor screening studies
Taguchi design was used for screening of CMPs. The first-order polynomial equation for response variables was generated and analyzed. The equation 1 shows the coefficients β1 to β7 represent the model terms, and the coefficient β0 representing the intercept term, Y represents response while 1 − 7 are factors.
The polynomial equation generated during the screening shows that there were absence of significant interaction effect(s) among the factors. Figure 3 shows the Pareto charts portraying the effect(s) of CMPs on method CAAs. During the screening it was found that the influence of factors viz. mobile phase ratio and saturation time on CAAs was statistically significant (p ˂ 0.05), and therefore only these factors were considered during the optimization.
Method development as per the experimental design and statistical analysis
Experimental runs of design were executed in random order to minimize bias. Polynomial equations were obtained for Rf, Peak-area and Peak -height using design expert software version 9.0.6.2. as described in equations (2) - (4) as follows:
where Y1 (Rf value), Y2 (Area) and Y3 (Height) are responses, X1 (Mobile phase ratio), and X2 (Chamber saturation time) are the factors. Table 5 shows the results of analysis of variance (ANOVA) of model for Rf value, area and height of the chromatogram of AGP. It is confirmed that model was statically significant in its prediction of Rf value, Peak-area and Peak-height as portrayed by probability value of less than 0.05. All quadratic terms were found statically significant for response Rf value, Peakarea and Peak-height AGP.
As per the values of coefficients from the polynomial models and their signs (Eqs. (2) -(4)), X1(mobile phase ratio) have negative effect on responses Y1 (Rf value) and positive effect on Y2 (Peak-area) and Y3 (Peak-height) while X2 (chamber saturation time) have positive effect on Y1 (Rf value), Y2 (Peak-area) and Y3 (Peak-height).
Response surface plots were analyzed to visualize the effect of parameters on response. Figure 4a shows the effect of mobile phase ratio (X1) and chamber saturation time (X2) on Rf value (Y1) of AGP. Figure 4b shows the effect of mobile phase ratio (X1) and chamber saturation time (X2) on Peak-area (Y2) of AGP. Figure 4c shows the effect of mobile phase ratio (X1) and chamber saturation time (X2) on Peak-height (Y3) of AGP.
Response surface plot depicted saturation time has less influence on Rf value and Peakarea than mobile phase ratio. While mobile phase ratio and saturation time, both are having near about same influence on Peak-height. When dichloromethane content in mobile phase increases, Rf value of AGP decreases while increase in saturation times leads to increase in Rf value as well 
Numerical Optimization
A numerical optimization technique by desirability approach was used to obtain optimum conditions for the HPTLC method of AGP.
The numerical optimization suggested the optimized conditions having mobile phase composition containing dichloromethane: methanol (8.2: 0.8 v/v) and chamber saturation time of 20 minutes with desirability of 0.990. The typical chromatogram of AGP is shown in Figure  5 .
Validation of Method
Linearity
Calibration curves were constructed by plotting peak area against concentration per band. A good linearity was obeyed in the concentration range of 100 -600 ng per band. Linear regression equation was found to be Y = 5.252 X + 767.9. The regression coefficient (r 2 = 0.999) is generally considered as evidence of acceptable fit. All measurements were repeated six times. 
Repeatability and Intermediate Precision study
The precision of the method was studied as repeatability and intermediate precision.
The precision of the developed HPTLC method was expressed in terms of % relative standard deviation (% RSD). The results from study of precision are shown in Table 6 . The established method was found to be precised as the % RSD values for repeatability and intermediate precision studies were < 2%, respectively as recommended by ICH guideline.
% Recovery study
The accuracy of the method is studied to assess that other components in the pharmaceutical formulation do not interfere with analytical method.
When the method was used for extraction and subsequent analysis of AGP in tablet dosage forms after spiking with 80, 100, or 120% excess drug the recovery was found 98.62 -99.46%, as listed in Table 7 . 
Conditions % RSD
Mobile phase ratio (± 0.1 mL) 1.62
Mobile phase volume ( ± 2 mL) 1.58
Development distance ( ± 0.5) 0.68
Saturation time ( ± 5) 1.02
Time from spotting to chromatography (± 10 min.) 0.87
Time from chromatography to scanning (± 10 min.) 0.92
Robustness
The standard deviation of peak areas was calculated for each condition and % RSD was less than 2%. The low values of % RSD are indicative of the robustness of the method. The results of robustness studies are shown in Table 8 .
Detection Limit (DL) and Quantification Limit (QL)
Detection Limit and Quantification Limit for signal-to-noise ratios of 3:1 and 10:1 were 8.74 ng and 26.51 ng, respectively, which indicate adequate sensitivity of the method.
Specificity
The peak purity of AGP was assessed by comparing the spectra at peak-start, peak -apex and peak-end positions of the spot, i.e., r 2 (S, M) = 0.996 and r 2 (M, E) = 0.998. Good correlation (r 2 = 0.99) was also obtained between standard and sample spectra of AGP.
These correlation values indicate the ability of the method to separate and specifically detect AGP from sample solutions.
Analysis of Tablet formulation
Using the proposed chromatographic method, assay of AGP in in-house tablets was carried out. The peak at Rf for AGP was observed in the densitogram of the drug samples extracted from Tablets. There was no interference observed from the excipients used in the formulation of in-house Anagliptin tablets. The drug content ± SD was found to be 99.41 ± 1.24 for Anagliptin.
CONCLUSION
The developed HPTLC method for the estimation of Anagliptin is simple, precise, rugged and robust. Further, the method is found to be accurate and sensitive. QbD is successfully implemented for optimization of mobile phase of NP-HPTLC method.
